Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

A nanobody against the VWF A3 domain detects ADAMTS13-induced proteolysis in congenital and acquired VWD

Blood (2023) 141 (12): 1457–1468.

https://doi.org/10.1182/blood.2022017569

Published: 2023

Includes: Supplemental data

Journal Articles

Multicenter Pharmacokinetic Evaluation of rFVIII-Fc (Elocta) in a Real Life and Comparison with Non-Extended Half-Life FVIII Concentrates

Claire Pouplard, PharmD, PhD, Laurent Sattler, Anne Ryman, Valérie Eschwege, Emmanuel De Maistre, Claire Flaujac, Jean Szymezak, François Grand, Yohann Repesse, Hubert Galinat, Magali Donnard, Catherine Ternisien, Emmanuelle Jeanpierre

Blood (2018) 132 (Supplement 1): 1196.

https://doi.org/10.1182/blood-2018-99-110036

Published: 2018

Journal Articles

Mutations in the A3 domain of Von Willebrand factor inducing combined qualitative and quantitative defects in the protein

Paulette Legendre, Ana-Maria Navarrete, Julie Rayes, Caterina Casari, Pierre Boisseau, Catherine Ternisien, Claudine Caron, Edith Fressinaud, Jenny Goudemand, Agnès Veyradier, Cécile V. Denis, Peter J. Lenting, Olivier D. Christophe

Blood (2013) 121 (11): 2135–2143.

https://doi.org/10.1182/blood-2012-09-456038

Published: 2013

Includes: Supplemental data

Journal Articles

Prospective Evaluation of a Rapid Nanoparticle-Based Lateral Flow Immunoassay (Stic Expert HIT ® ) for the Diagnosis of Heparin-Induced Thrombocytopenia

Claire Pouplard, PharmD, PhD, Dorothee Leroux, PharmD, Nathalie Hezard, MD, PhD, Aurelien Lebreton, MD, Anne Bauters, MD, William Cohen, Emmanuel De Maistre, MD, Isabelle Diaz, Pharm D, Marie-Genevieve Huisse, Catherine Ternisien, MD, Sophie Voisin, MD, Yves Gruel, MD, PhD

Blood (2012) 120 (21): 1087.

https://doi.org/10.1182/blood.V120.21.1087.1087

Published: 2012

Journal Articles

Monitoring Treatments with Unfractionated Heparin: CTAD Must Be Used Instead of Citrate as the Anticoagulant Solution When Using Partial-Draw Collection Tubes.

Pierre A. Toulon, MD, PhD, Lién Abecassis, MD, Motalib Smahi, MD, Catherine Ternisien, MD

Blood (2009) 114 (22): 2091.

https://doi.org/10.1182/blood.V114.22.2091.2091

Published: 2009

Journal Articles

Acquired Factor IX (fIX) Deficiency Associated with a Multiple Myeloma.

Severine Lissandre, MD, Catherine Ternisien, MD, Marie-Christine Rousselet, MD, Aline Tanguy-Schmidt, MD, Norbert Ifrah, MD PhD, Mathilde Hunault-Berger, MD PhD

Blood (2006) 108 (11): 4061.

https://doi.org/10.1182/blood.V108.11.4061.4061

Published: 2006

Journal Articles

Prospective Evaluation of 4T’s Score and Rapid Particle Gel Immuno-Assay Specific to H/PF4 Complexes To Exclude Heparin-Induced Thrombocytopenia.

Claire Pouplard, PharmD, Marc Fouassier, MD, Catherine Ternisien, MD, Pierre Gueret, MD, Marc Trossaert, MD, Sandra Regina, MD, Yves Gruel, MD

Blood (2005) 106 (11): 1244.

https://doi.org/10.1182/blood.V106.11.1244.1244

Published: 2005

Journal Articles

Predictive Diagnostic and Prognostic Value of Platelets Microparticles (PMP), but Not of Reticulated Platelets (RP) or CD36 Expression in Essential Thrombocythaemia.

Catherine Ternisien, MD-PhD, Marie-Pierre Moles, Aline Tanguy-Schmidt, Irene Dobo, Martine Gardembas, MD, Franck Geneviève, MD, Marc Zandecki, PhD, Norbert Ifrah, MD, Mathilde Hunault-Berger, MD-PhD

Blood (2004) 104 (11): 4745.

https://doi.org/10.1182/blood.V104.11.4745.4745

Published: 2004

Journal Articles

The arginine-552-cysteine (R1315C) mutation within the A1 loop of von Willebrand factor induces an abnormal folding with a loss of function resulting in type 2A–like phenotype of von Willebrand disease: study of 10 patients and mutated recombinant von Willebrand factor

Anne-Sophie Ribba, Lysiane Hilbert, Jean-Maurice Lavergne, Edith Fressinaud, Catherine Boyer-Neumann, Catherine Ternisien, Irène Juhan-Vague, Jenny Goudemand, Jean-Pierre Girma, Claudine Mazurier, Dominique Meyer

Blood (2001) 97 (4): 952–959.

https://doi.org/10.1182/blood.V97.4.952

Published: 2001

NARROW

A nanobody against the VWF A3 domain detects ADAMTS13-induced proteolysis in congenital and acquired VWD

Multicenter Pharmacokinetic Evaluation of rFVIII-Fc (Elocta) in a Real Life and Comparison with Non-Extended Half-Life FVIII Concentrates

Mutations in the A3 domain of Von Willebrand factor inducing combined qualitative and quantitative defects in the protein

Prospective Evaluation of a Rapid Nanoparticle-Based Lateral Flow Immunoassay (Stic Expert HIT ® ) for the Diagnosis of Heparin-Induced Thrombocytopenia

Monitoring Treatments with Unfractionated Heparin: CTAD Must Be Used Instead of Citrate as the Anticoagulant Solution When Using Partial-Draw Collection Tubes.

Acquired Factor IX (fIX) Deficiency Associated with a Multiple Myeloma.

Prospective Evaluation of 4T’s Score and Rapid Particle Gel Immuno-Assay Specific to H/PF4 Complexes To Exclude Heparin-Induced Thrombocytopenia.

Predictive Diagnostic and Prognostic Value of Platelets Microparticles (PMP), but Not of Reticulated Platelets (RP) or CD36 Expression in Essential Thrombocythaemia.

The arginine-552-cysteine (R1315C) mutation within the A1 loop of von Willebrand factor induces an abnormal folding with a loss of function resulting in type 2A–like phenotype of von Willebrand disease: study of 10 patients and mutated recombinant von Willebrand factor

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only